Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer.

Voss, M.A., Gordon, N., Maloney, S. et al. (8 more authors) (2011) Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. British Journal of Cancer, 104 (10). pp. 1611-1618. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2011 Cancer Research UK. Twelve months after publication in British Journal of Cancer, the Contribution, as published on the BJC website, will be offered for reuse under the terms of the Creative Commons Attribution-NonCommercial-Share-Alike 3.0 licence, subject to the conditions listed at http://creativecommons.org/licences/by-nc-sa/3.0/
Keywords: Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, CD151; Biomarkers, Tumor; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Prognosis
Dates:
  • Published: 10 May 2011
  • Published (online): 19 April 2011
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Department of Neuroscience (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 25 Jul 2016 14:18
Last Modified: 25 Jul 2016 14:18
Published Version: http://dx.doi.org/10.1038/bjc.2011.80
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/bjc.2011.80
Related URLs:

Share / Export

Statistics